The American Journal of Managed Care24 年
Characterizing Patients With MDS Who Undergo Allo-HSCT
Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients, according to ...
Salarius announces patient enrollment to resume for trial on seclidemstat
Salarius Pharmaceuticals (SLRX) announces that patient enrollment will resume in the investigator-initiated Phase 1/2 clinical trial evaluating ...
Salarius resumes trial for MDS and CMML treatment
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) has announced the resumption of patient enrollment in a Phase 1/2 clinical trial evaluating seclidemstat combined with azacitidine for myelodysplastic ...